STAT+: GLP-1s are given an FDA warning for rare eye condition risk

AI Summary

The FDA warned that GLP-1 medications may carry a risk of a rare but serious eye condition sometimes called an “eye stroke.” The brief report does not identify specific drugs or provide further details about the warning.

The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”